Author of the publication

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Assessment and prognostic significance of the epidermal growth factor receptor vIII mutation in glioblastoma patients treated with concurrent and adjuvant temozolomide radiochemotherapy, , , , , , , , , and 6 other author(s). Int J Cancer, 134 (10): 2437-2447 (May 2014)Feasibility of real-time molecular profiling for patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation-the NCT Neuro Master Match (N2M2) pilot study, , , , , , , , , and 11 other author(s). Neuro Oncol, 20 (6): 826-837 (May 2018)Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas, , , , , , , , , and 7 other author(s). Acta Neuropathol, 118 (4): 469-474 (October 2009)NDRG1 prognosticates the natural course of disease in WHO grade II glioma, , , , , , , , , and 18 other author(s). J Neurooncol, 117 (1): 25-32 (March 2014)Long-term survival in primary glioblastoma with versus without isocitrate dehydrogenase mutations, , , , , , , , , and 2 other author(s). Clin Cancer Res, 19 (18): 5146-5157 (September 2013)Evolutionary Trajectories of IDHWT Glioblastomas Reveal a Common Path of Early Tumorigenesis Instigated Years ahead of Initial Diagnosis, , , , , , , , , and 15 other author(s). Cancer Cell, 35 (4): 692-704 (April 2019)Tweety-Homolog 1 Drives Brain Colonization of Gliomas, , , , , , , , , and 12 other author(s). J Neurosci, 37 (29): 6837-6850 (July 2017)NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide, , , , , , , , , and 10 other author(s). J Clin Oncol, 27 (35): 5874-5880 (December 2009)Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study, , , , , , , , , and 27 other author(s). Lancet Oncol, 17 (11): 1521-1532 (November 2016)Expression-based intrinsic glioma subtypes are prognostic in low-grade gliomas of the EORTC22033-26033 clinical trial, , , , , , , , , and 14 other author(s). Eur J Cancer, (May 2018)